Retraction Note: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Retraction Note: Cancer Nanotechnology (2023) 14:65 https://doi.org/10.1186/s12645-023-00218-2

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding some of the images presented in the figures, specifically:

• Fig. 6 appears highly similar to Fig. 10 of Naseer et al. (2023)

• Fig. 6 Pure VC 12 h 90 ug/ml and VC-loaded TCs-HA 24 h 50 ug/ml images appear highly similar

• Fig. 17 A5 and Fig. 18 D5 images appear to overlap (flipped and with different magnification)

• Fig. 18 C6 and D6 appear to overlap (with different magnification)

• Several panels in Figs. 17 and 18 appear highly similar to those in Fig. 8 of Kousar et al. (2023)

The authors have been unable to provide the underlying raw data upon request. The Editors-in-Chief therefore no longer have confidence in the presented data.

None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.